Sponsored content brought to you by Bispecific antibodies (bispecifics) can simultaneously target two distinct antigens or epitopes, offering novel therapeutic…

2024 had its dazzling moments, but, in the end, it was a year of treading water for biopharma stocks, judging…

New research from scientists at the University of Washington (UW) School of Medicine and Duke University describes how cellular RNA…

Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding…

The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…

Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…

Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…

Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…

The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…